Abstract
This editorial summarizes advances from the Clearance of Interstitial Fluid and Cerebrospinal Fluid (CLIC) group, within the Vascular Professional Interest Area (PIA) of the Alzheimer’s Association International Society to Advance Alzheimer’s Research and Treatment (ISTAART). The overarching objectives of the CLIC group are to: (1) understand the age-related physiology changes that underlie impaired clearance of interstitial fluid (ISF) and cerebrospinal fluid (CSF) (CLIC); (2) understand the cellular and molecular mechanisms underlying intramural periarterial drainage (IPAD) in the brain; (3) establish novel diagnostic tests for Alzheimer’s disease (AD), cerebral amyloid angiopathy (CAA), retinal amyloid vasculopathy, amyloid-related imaging abnormalities (ARIA) of spontaneous and iatrogenic CAA-related inflammation (CAA-ri), and vasomotion; and (4) establish novel therapies that facilitate IPAD to eliminate amyloid β (Aβ) from the aging brain and retina, to prevent or reduce AD and CAA pathology and ARIA side events associated with AD immunotherapy.
If you do not see content above, kindly GO TO SOURCE.
Not all publishers encode content in a way that enables republishing at Neuro.vip.
This post is Copyright: Louise Kelly,
Christopher Brown,
Daniel Michalik,
Cheryl A. Hawkes,
Roxana Aldea,
Nivedita Agarwal,
Rami Salib,
Aiman Alzetani,
Douglas W Ethell,
Scott E. Counts,
Mony de Leon,
Silvia Fossati,
Maya Koronyo‐Hamaoui,
Fabrizio Piazza,
Steven A. Rich,
Frank J. Wolters,
Heather Snyder,
Ozama Ismail,
Fanny Elahi,
Steven T. Proulx,
Ajay Verma,
Hilary Wunderlich,
Mareike Haack,
Jean Cosme Dodart,
Norman Mazer,
Roxana O. Carare | October 29, 2023